오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trisodium caloxetate; trometamol; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trometamol; sodium hydroxide; hydrochloric acid; water for injections; trisodium caloxetate - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; trisodium caloxetate; water for injections; sodium hydroxide; trometamol - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trisodium caloxetate; sodium hydroxide; trometamol; water for injections; hydrochloric acid - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; trisodium caloxetate; trometamol; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trometamol; trisodium caloxetate; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

싱가포르 - 영어 - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - gadoxetate, disodium - injection, solution - 181.430mg - gadoxetate, disodium 181.430mg

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate -

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

bayer new zealand limited - gadoxetate disodium 181.43 mg/ml (manufactured in-situ from gadolinium oxide and ethoxybenzyl dtpa) - solution for injection - 181.43 mg/ml - active: gadoxetate disodium 181.43 mg/ml (manufactured in-situ from gadolinium oxide and ethoxybenzyl dtpa) excipient: hydrochloric acid as 3.6% w/w aqueous solution caloxetate complexing agent sodium hydroxide trometamol water for injection - for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesions

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

bayer limited - gadoxetic acid, disodium - solution for injection in pre-filled syringe - 0.25 millimole(s)/millilitre - paramagnetic contrast media; gadoxetic acid